In order to get a better understanding of the pharmaceutical market in Indonesia, our OKCHEM team in Indonesia visited the Indonesian Pharmaceutical Association on Apr. 2.

As the most influential association in pharmaceutical industry, Indonesian Pharmaceutical Association was established in 1969. Its members include the largest pharmaceutical companies in Indonesia, such as Kalbe Farma, Sanbe Farma. Besides, the association has close contact with Chinese Pharmaceutical Association.

This visit was warmly accepted by Mr. Tirto, President & CEO of the association, and Mr.Vincent Harijanto, Head of Committee. The two gentlemen told us that active pharmaceutical ingredient (API) has great market and developing potentiality in Indonesia. They introduced that Amoxicillin has been used for several decades in this country with an annual consumption of 300MT. They mainly imported the product from China and India because of the price advantages. They also expressed that the export of API to Indonesia doesn’t need to be registered, but suppliers must provide DMF certificate. Besides API, other medical intermediates are also in great demand in this country, so it is a great opportunity for Chinese suppliers and they also expected that Chinese companies would invest and build plant in the this region. 

In view of this situation, we talked about our sourcing solutions, which can help buyers to find the most reliable suppliers and provide the most suitable trade services. The two leaders were very interested in our services. They hoped that OKCHEM and Indonesian Pharmaceutical Association can join hands in developing pharmaceutical market in Indonesia.

Know More about OKCHEM in Indonesia